Skip to main content

Diametric Capital, LP

SEC CIK
0001719087
Latest filing
Aug 14, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2025
Holdings of NTLA by Diametric Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−11,553−100.0%Sold outHolders
Q3 202511,553$199.5K0.1%−25,234−68.6%ReducedHolders
Q2 202536,787$345.1K0.2%−8,639−19.0%ReducedHolders
Q1 202545,426$323.0K0.4%+45,426NewHolders